At Janssen everything we do is engineered with the patient in mind. It drives us to search for new ideas and innovative healthcare solutions. We embrace challenges and develop treatments that will change the lives of our patients.
As a leading research-based pharmaceutical company, we employ more than 320 staff in Australia and New Zealand. All committed to delivering value to our patients and their families.
We focus on some of the most devastating diseases and solving some of the most complex medical challenges of our time. Our four priority disease areas are:
- Immunology (e.g. rheumatoid arthritis and Crohn’s Disease)
- Infectious Diseases & Vaccines (e.g. HIV/AIDS and Hepatitis C).
- Oncology (e.g. prostate cancer, multiple myeloma and chronic lymphocytic leukaemia)
- Neuroscience (e.g. schizophrenia)
- Pulmonary Hypertension
- Our Response to COVID-19
Today’s medical challenges are far more complex than ever before. That’s why we never limit the search for new medicines to our own four walls. We look at the world as our lab, seeking innovative ideas wherever they occur.
We believe in connecting our own expertise and capabilities with those of others, seeking the most creative minds in every field. Together we can find transformational solutions.
At Janssen, we collaborate with the world for the health of everyone in it.